0001209191-22-001736.txt : 20220105
0001209191-22-001736.hdr.sgml : 20220105
20220105164031
ACCESSION NUMBER: 0001209191-22-001736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trower Paul
CENTRAL INDEX KEY: 0001642041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 22511752
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-03
0
0000879169
INCYTE CORP
INCY
0001642041
Trower Paul
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
Principal Accounting Officer
Common Stock
2022-01-03
4
M
0
6818
73.21
A
39086
D
Common Stock
2022-01-03
4
S
0
6818
73.31
D
32268
D
Common Stock
2022-01-03
4
M
0
1396
73.21
A
33664
D
Common Stock
2022-01-03
4
S
0
1396
73.31
D
32268
D
Non- Qualified Stock Option (right to buy)
73.21
2022-01-03
4
M
0
6818
0.00
D
2022-01-07
Common Stock
6818
0
D
Incentive Stock Option (right to buy)
73.21
2022-01-03
4
M
0
1396
0.00
D
2022-01-07
Common Stock
1396
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Includes an aggregate of 17,780 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Paul Trower
2022-01-05